A Multi-centre, Randomised, Double-blind, Placebo and Entacapone Controlled, Parallel Group Study of the Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations

Trial Profile

A Multi-centre, Randomised, Double-blind, Placebo and Entacapone Controlled, Parallel Group Study of the Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations

Discontinued
Phase of Trial: Phase III

Latest Information Update: 12 Sep 2014

At a glance

  • Drugs Perampanel (Primary) ; Entacapone
  • Indications Parkinson's disease
  • Focus Registrational; Therapeutic Use
  • Sponsors Eisai Co Ltd
  • Most Recent Events

    • 04 Jan 2012 Results published in Clinical Neuropharmacology.
    • 09 Sep 2009 Official Title added as reported by ClinicalTrials.gov.
    • 09 Sep 2009 New source identified and integrated (ClinicalTrials.gov record no. NCT00360308).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top